NASDAQ:JYNTJoint Stock Price, Forecast & News

Joint's stock was trading at $13.61 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, JYNT stock has increased by 6.5% and is now trading at $14.50. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Joint.

Joint is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Joint.

Joint Corp (NASDAQ:JYNT) announced its earnings results on Thursday, May, 7th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.01. The firm earned $13.64 million during the quarter, compared to analyst estimates of $13.03 million. Joint had a net margin of 6.20% and a return on equity of 66.44%. View Joint's earnings history.

5 Wall Street analysts have issued twelve-month price targets for Joint's stock. Their forecasts range from $20.00 to $30.00. On average, they anticipate Joint's share price to reach $23.40 in the next year. This suggests a possible upside of 61.4% from the stock's current price. View analysts' price targets for Joint.

Media stories about JYNT stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Joint earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Joint.

Joint saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 1,730,000 shares, a drop of 7.5% from the May 31st total of 1,870,000 shares. Based on an average trading volume of 161,900 shares, the days-to-cover ratio is currently 10.7 days. Currently, 13.2% of the company's stock are sold short. View Joint's Current Options Chain.

Some companies that are related to Joint include Liberty Tax (TAXA), Acacia Research (ACTG), Quarterhill (QTRHF), Quarterhill (QTRH), Research Frontiers (REFR), Finjan (FNJN), Marathon Patent Group (MARA), XCel Brands (XELB), MGT Capital Investments (MGTI), Spherix (SPEX), Health Discovery (HDVY), Micro Imaging Technology (MMTC), ARC Group (ARCK), American Restaurant Partners LP Class A Partnership Units (ICTPU) and Fortel (ECGP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Ring Energy (REI), Ring Energy (REI), Walt Disney (DIS), Starbucks (SBUX), Viking Therapeutics (VKTX), Adobe (ADBE), Catalyst Pharmaceuticals (CPRX) and Corbus Pharmaceuticals (CRBP).

(JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of JYNT stock can currently be purchased for approximately $14.50.

Joint has a market capitalization of $202.13 million and generates $48.45 million in revenue each year. The company earns $3.32 million in net income (profit) each year or $0.23 on an earnings per share basis. Joint employs 138 workers across the globe.

The official website for Joint is www.thejoint.com.

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected]